Published in Biophys J on April 01, 1988
Binding of a monoclonal antibody and its Fab fragment to supported phospholipid monolayers measured by total internal reflection fluorescence microscopy. Biophys J (1990) 1.49
Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol (1998) 1.28
Evanescent interference patterns for fluorescence microscopy. Biophys J (1992) 1.00
Degradation of adsorbed protein by attached bacteria in relationship to surface hydrophobicity. Appl Environ Microbiol (1990) 1.00
Binding kinetics of an anti-dinitrophenyl monoclonal Fab on supported phospholipid monolayers measured by total internal reflection with fluorescence photobleaching recovery. Biophys J (1992) 0.94
Molecular orientation distributions in protein films: III. Yeast cytochrome c immobilized on pyridyl disulfide-capped phospholipid bilayers. Biophys J (1998) 0.90
Absorption spectra indicate conformational alteration of myoglobin adsorbed on polydimethylsiloxane. Biophys J (1995) 0.83
Competitive adsorption of human immunoglobulin G and albumin: consequences for structure and reactivity of the adsorbed layer. Proc Natl Acad Sci U S A (1992) 0.81
Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological Theory. Int J Mol Sci (2016) 0.75
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry (1978) 22.56
Radioactive labeling of proteins in vitro. J Biol Chem (1971) 6.99
Structure and refinement of oxymyoglobin at 1.6 A resolution. J Mol Biol (1980) 4.09
Rapid fluorescein and protein assay method for fluorescent-antibody conjugates. Appl Microbiol (1966) 2.84
Comparison of myoglobins from harbor seal, porpoise, and sperm whale. I. Preparation and characterization. J Biol Chem (1968) 1.83
Adsorption characteristics of plasma fibronectin in relationship to biological activity. J Biomed Mater Res (1981) 1.67
Mechanism of binding of multivalent immune complexes to Fc receptors. 1. Equilibrium binding. Biochemistry (1981) 1.56
Topographic antigenic determinants recognized by monoclonal antibodies to sperm whale myoglobin. J Biol Chem (1982) 1.24
Genetic control of the immune response to mammalian myoglobins in mice I. More than one I-region gene in H-2 controls the antibody response. J Immunol (1978) 1.19
Properties of monoclonal antibodies specific for determinants of a protein antigen, myoglobin. J Biol Chem (1980) 1.18
Some monoclonal antibodies raised with a native protein bind preferentially to the denatured antigen. Mol Immunol (1984) 1.15
Sulfheme proteins. I. Optical and magnetic properties of sulfmyoglobin and its derivatives. J Biol Chem (1971) 1.14
Functional heterogeneity of monoclonal antibodies obtained using different screening assays. Anal Biochem (1983) 1.09
Idiotypes of anti-myoglobin antibodies: shared idiotypes among monoclonal antibodies to distinct determinants of sperm whale myoglobin. J Immunol (1982) 1.05
Use of monoclonal antibodies to detect conformational alterations in lactate dehydrogenase isoenzyme 5 on heat denaturation and on adsorption to polystyrene plates. Mol Immunol (1986) 1.02
Total internal reflection fluorescence study of energy transfer in surface-adsorbed and dissolved bovine serum albumin. Biochemistry (1983) 0.94
Recognition of primary sequence variations among sperm whale myoglobin components with successive proteolysis procedures. J Biol Chem (1974) 0.89
Platelet attachment and spreading on polystyrene surfaces: dependence on fibronectin and plasma concentration. Thromb Res (1985) 0.85
A rapid solution-phase screening technique for hybridoma culture supernatants using radiolabeled antigen and a solid-phase immunoadsorbent. J Immunol Methods (1983) 0.84
Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet (1993) 6.39
The antigenic structure of proteins: a reappraisal. Annu Rev Immunol (1984) 5.31
T-cell antigenic sites tend to be amphipathic structures. Proc Natl Acad Sci U S A (1985) 5.05
Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J Immunol (1987) 4.95
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol (2000) 4.75
An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1988) 4.72
Prying open the door to the tobacco industry's secrets about nicotine: the Minnesota Tobacco Trial. JAMA (1998) 4.61
Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci U S A (1996) 4.11
Hydrophobicity scales and computational techniques for detecting amphipathic structures in proteins. J Mol Biol (1987) 4.07
Intrinsic and extrinsic factors in protein antigenic structure. Science (1985) 3.54
Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev (1992) 3.30
Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis (1992) 3.27
Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature (1990) 3.15
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest (1994) 3.12
Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci U S A (1993) 2.65
Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc Natl Acad Sci U S A (1988) 2.60
Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature (1988) 2.56
Dynamics of glomerular ultrafiltration in the rat. IV. Determination of the ultrafiltration coefficient. J Clin Invest (1973) 2.55
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science (1993) 2.35
Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc Natl Acad Sci U S A (1998) 2.33
A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. Science (1989) 2.32
A model of glomerular ultrafiltration in the rat. Am J Physiol (1972) 2.32
Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. Science (1987) 2.24
Dynamics of glomerular ultrafiltration in the rat. II. Plasma-flow dependence of GFR. Am J Physiol (1972) 2.24
Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J Immunol (1991) 2.17
The murine Kupffer cell. I. Characterization of the cell serving accessory function in antigen-specific T cell proliferation. J Immunol (1979) 2.15
Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. J Immunol (1992) 2.14
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med (2001) 2.10
Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med (1990) 2.09
Distinct H-2-linked Ir genes control both antibody and T cell responses to different determinants on the same antigen, myoglobin. Proc Natl Acad Sci U S A (1979) 2.06
Performance of the polypropylene fiber tailstring on the Copper 7 intrauterine device. J Appl Biomater (1991) 2.05
ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest (1995) 2.04
Antigen conformation determines processing requirements for T-cell activation. Proc Natl Acad Sci U S A (1984) 1.94
Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant. Science (1992) 1.89
Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine. J Exp Med (1986) 1.89
Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. J Immunol (1994) 1.87
Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions. Kidney Int (1975) 1.83
Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature (1989) 1.80
Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J Exp Med (1996) 1.78
The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J Clin Invest (1998) 1.77
Identification of distinct predominant epitopes recognized by myoglobin-specific T cells under the control of different Ir genes and characterization of representative T cell clones. J Immunol (1984) 1.75
CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol (1995) 1.72
An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol (1994) 1.68
T cell clones to two major T cell epitopes of myoglobin: effect of I-A/I-E restriction on epitope dominance. J Immunol (1985) 1.66
Genetic control of immunity to Plasmodium yoelii sporozoites. J Immunol (1989) 1.66
Surface diffusion of interacting proteins. Effect of concentration on the lateral mobility of adsorbed bovine serum albumin. Biophys J (1990) 1.64
Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran. Biophys J (1975) 1.64
Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. Proc Natl Acad Sci U S A (1999) 1.63
Dynamics of glomerular ultrafiltration in the rat. 3. Hemodynamics and autoregulation. Am J Physiol (1972) 1.63
Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. J Immunol (1989) 1.63
Dynamics of glomerular ultrafiltration in the rat. VII. Response to reduced renal mass. Am J Physiol (1974) 1.62
A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. J Immunol (1992) 1.62
Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope. J Infect Dis (1996) 1.61
Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. J Immunol (1996) 1.60
A total internal-reflection technique for the examination of protein adsorption. J Biomed Mater Res (1977) 1.56
Downloadable computer models for renal replacement therapy. Kidney Int (2006) 1.56
Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity (1997) 1.55
Molecular mapping of a histocompatibility-restricted immunodominant T cell epitope with synthetic and natural peptides: implications for T cell antigenic structure. J Immunol (1986) 1.55
An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself. J Exp Med (1990) 1.54
Permselectivity of the glomerular capillary wall. Facilitated filtration of circulating polycations. J Clin Invest (1978) 1.53
Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected]. J Infect Dis (1991) 1.53
Clinical trial designs for the early clinical development of therapeutic cancer vaccines. J Clin Oncol (2001) 1.52
Retracted Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model. Proc Natl Acad Sci U S A (2000) 1.51
Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice. Gastroenterology (1997) 1.50
Influences of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing. J Exp Med (1988) 1.50
Antibody conjugates mimic specific B cell presentation of antigen: relationship between T and B cell specificity. J Immunol (1987) 1.50
Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. J Immunol (1992) 1.46
Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. J Exp Med (1992) 1.46
Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules. J Clin Invest (1977) 1.46
Interleukin 2 receptor expression in unstimulated murine splenic T cells. Localization to L3T4+ cells and regulation by non-H-2-linked genes. J Exp Med (1986) 1.44
In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10. J Infect Dis (1996) 1.41
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res (1996) 1.39
Strong conformational propensities enhance T cell antigenicity. J Immunol (1987) 1.39
Renal medullary microcirculation. Physiol Rev (1990) 1.37
HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA (1994) 1.36
Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein. J Exp Med (1989) 1.35
Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int Immunol (1993) 1.34
T-B reciprocity. An Ia-restricted epitope-specific circuit regulating T cell-B cell interaction and antibody specificity. Surv Immunol Res (1983) 1.33
A possible immunodominant epitope recognized by murine T lymphocytes immune to different myoglobins. Proc Natl Acad Sci U S A (1982) 1.31
Influence of molecular configuration on the passage of macromolecules across the glomerular capillary wall. J Gen Physiol (1979) 1.30
Identification of proteases that process distinct epitopes on the same protein. J Immunol (1989) 1.30
Permselectivity of the glomerular capillary wall to macromolecules. I. Theoretical considerations. Biophys J (1975) 1.30
The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development. Annu Rev Immunol (1988) 1.29
An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1990) 1.28
Minimal requirements for peptide mediated activation of CD8+ CTL. Mol Immunol (1994) 1.28
Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate. J Clin Invest (1976) 1.27
Platelet aggregation by laminar shear and Brownian motion. Ann Biomed Eng (1976) 1.26
Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15. J Exp Med (1995) 1.25
Topographic antigenic determinants recognized by monoclonal antibodies to sperm whale myoglobin. J Biol Chem (1982) 1.24
The role of CD4+ T cells in immunity to malaria sporozoites. J Immunol (1993) 1.24
Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol (1977) 1.23
A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells. Cancer Res (1993) 1.22